Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3VXS

The complex between H27-14 TCR and HLA-A24 bound to HIV-1 Nef134-10(6L) peptide

Summary for 3VXS
Entry DOI10.2210/pdb3vxs/pdb
Related3VXM 3VXN 3VXO 3VXP 3VXQ 3VXR 3VXT 3VXU
DescriptorHLA class I histocompatibility antigen, A-24 alpha chain, Beta-2-microglobulin, H27-14 TCR alpha chain, ... (6 entities in total)
Functional Keywordshiv-1, nef, immune system, hla-a24, t cell receptor, mhc class i, immunogloburin domain, tcr, mhc, immune response
Biological sourceHomo sapiens (human)
More
Cellular locationMembrane; Single-pass type I membrane protein: P05534
Secreted: P61769
Total number of polymer chains5
Total formula weight95550.20
Authors
Shimizu, A.,Fukai, S.,Yamagata, A.,Iwamoto, A. (deposition date: 2012-09-20, release date: 2013-10-23, Last modification date: 2024-10-30)
Primary citationShimizu, A.,Kawana-Tachikawa, A.,Yamagata, A.,Han, C.,Zhu, D.,Sato, Y.,Nakamura, H.,Koibuchi, T.,Carlson, J.,Martin, E.,Brumme, C.J.,Shi, Y.,Gao, G.F.,Brumme, Z.L.,Fukai, S.,Iwamoto, A.
Structure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infection
SCI REP, 3:3097-3097, 2013
Cited by
PubMed Abstract: We investigated the crystal structure of an HLA-A*2402-restricted CTL epitope in the HIV-1 nef gene (Nef134-10) before (pHLA) or after TCR docking. The wild type epitope and two escape mutants were included in the study. Y135F was an early-appearing major mutation, while F139L was a late-appearing mutation which was selected in the patients without Y135F. F139 was an eminent feature of the Nef134-10 epitope. Wild type-specific TCR was less fit to F139L mutant suggesting that F139L is an escape from the CTL against the wild type epitope. Although Y135F mutation disrupted the hydrogen bond to HLA-A*2402 His70, newly formed hydrogen bond between T138 and His70 kept the conformation of the epitope in the reconstituted pMHC. TCR from Y135F- or dually-specific CTL had unique mode of binding to the mutant epitope. Y135F has been reported as a processing mutant but CTL carrying structurally adequate TCR can be found in the patients.
PubMed: 24192765
DOI: 10.1038/srep03097
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.8 Å)
Structure validation

227561

数据于2024-11-20公开中

PDB statisticsPDBj update infoContact PDBjnumon